Clinical Validation from Biopharmaceutical Findings
@cvbf.bsky.social
CVBF mission is to perform innovative research initiatives in the European scenario to enhance paediatric research from drug discovery to clinical phases.
The @who.int has designated the Clinical Trials Information System (#CTIS) as a primary registry - a key step in boosting transparency and trust in #clinicalresearch across the EU, ensuring global access to essential trial data.
The Clinical Trials Information System #CTIS has been designated as primary registry by the @who.int !
This designation represents a significant step forward in promoting transparency and trust in clinical research in the EU.
#clinicaltrials #clinicalresearch www.ema.europa.eu/en/news/clin...
This designation represents a significant step forward in promoting transparency and trust in clinical research in the EU.
#clinicaltrials #clinicalresearch www.ema.europa.eu/en/news/clin...
Clinical Trials Information System designated as WHO primary registry | European Medicines Agency (EMA)
Designation facilitates data sharing, promotes transparency and trust in clinical research
www.ema.europa.eu
April 4, 2025 at 9:08 AM
The @who.int has designated the Clinical Trials Information System (#CTIS) as a primary registry - a key step in boosting transparency and trust in #clinicalresearch across the EU, ensuring global access to essential trial data.
🔬 BREAKTHROUGH: CVBF is collaborating on the world's FIRST clinical trial of Mirtazapine for Rett Syndrome!
#ChildrenFirst #PaediatricResearch #RareDiseases #Rett #RettSyndrome #CVBF #ClinicalInnovation #Neurology
#ChildrenFirst #PaediatricResearch #RareDiseases #Rett #RettSyndrome #CVBF #ClinicalInnovation #Neurology
Consorzio per Valutazioni Biologiche e Farmacologiche (CVBF) on LinkedIn: #mirtarett #childrenfirst #paediatricresearch #rarediseases #rett…
🔬 MAJOR BREAKTHROUGH IN RETT SYNDROME RESEARCH 🔬
We are proud to announce that CVBF will collaborate as a clinical research service provider for the…
www.linkedin.com
March 3, 2025 at 2:52 PM
🔬 BREAKTHROUGH: CVBF is collaborating on the world's FIRST clinical trial of Mirtazapine for Rett Syndrome!
#ChildrenFirst #PaediatricResearch #RareDiseases #Rett #RettSyndrome #CVBF #ClinicalInnovation #Neurology
#ChildrenFirst #PaediatricResearch #RareDiseases #Rett #RettSyndrome #CVBF #ClinicalInnovation #Neurology
🎉 CVBF obtains the Family Audit Executive Certification!
We are proud to announce that CVBF has achieved the Family Audit Executive Certification, recognizing our commitment to promoting work-life balance policies and fostering organizational well-being.
We are proud to announce that CVBF has achieved the Family Audit Executive Certification, recognizing our commitment to promoting work-life balance policies and fostering organizational well-being.
January 14, 2025 at 3:18 PM
🎉 CVBF obtains the Family Audit Executive Certification!
We are proud to announce that CVBF has achieved the Family Audit Executive Certification, recognizing our commitment to promoting work-life balance policies and fostering organizational well-being.
We are proud to announce that CVBF has achieved the Family Audit Executive Certification, recognizing our commitment to promoting work-life balance policies and fostering organizational well-being.
🔬 An Analysis on Paediatric Post-Authorization Studies🧬
Our team has just published an analysis of paediatric Post-Authorization Studies, revealing critical insights into drug research for children.
For more info and the full paper: lnkd.in/dUcWy8_x
Our team has just published an analysis of paediatric Post-Authorization Studies, revealing critical insights into drug research for children.
For more info and the full paper: lnkd.in/dUcWy8_x
December 17, 2024 at 1:31 PM
🔬 An Analysis on Paediatric Post-Authorization Studies🧬
Our team has just published an analysis of paediatric Post-Authorization Studies, revealing critical insights into drug research for children.
For more info and the full paper: lnkd.in/dUcWy8_x
Our team has just published an analysis of paediatric Post-Authorization Studies, revealing critical insights into drug research for children.
For more info and the full paper: lnkd.in/dUcWy8_x
🌟CVBF at the Global CardioVascular Clinical Trialists Forum 🩺🔬
Want to know more? 👉 Full details available on our website: www.cvbf.net/news/cvbfs-c...
Want to know more? 👉 Full details available on our website: www.cvbf.net/news/cvbfs-c...
December 12, 2024 at 3:22 PM
🌟CVBF at the Global CardioVascular Clinical Trialists Forum 🩺🔬
Want to know more? 👉 Full details available on our website: www.cvbf.net/news/cvbfs-c...
Want to know more? 👉 Full details available on our website: www.cvbf.net/news/cvbfs-c...
Since its inception, CVBF has been more than just a research organization – it’s a mission-driven community dedicated to transforming the landscape of paediatric and rare disease research.
December 5, 2024 at 2:10 PM
Since its inception, CVBF has been more than just a research organization – it’s a mission-driven community dedicated to transforming the landscape of paediatric and rare disease research.